NH

Nancy Hong

Board Member at San Diego Symphony

San Diego Metropolitan Area

Overview

Work Experience

SD

San Diego Symphony

  • Board Member

    2021 - Current

B

Biolinq

  • Board Member

    2021 - 2023

BT

Bluejay Therapeutics

  • Board Member

    2021 - 2023

SD

SeQure Dx

  • Board Member

    2021 - 2023

SB

Scout Bio

  • Board Member

    2019 - 2023

RV

RiverVest Venture Partners

  • Managing Director

    2016 - 2023

    Dr. Hong focuses on biopharmaceutical and medical device opportunities and contributes to the formation, development and business strategies of RiverVest portfolio companies. Dr. Hong joined RiverVest in 2016 and is based in San Diego with Drs. Niall O’Donnell and Pascal Krotee.

XT

Xilio Therapeutics, Inc.

  • Board Member and Observer

    2019 - 2021

    NASDAQ: XLO

BR

BioMed Realty

  • Principal at BioMed Ventures

    2015 - 2016

  • Senior Associate at BioMed Ventures

    2013 - 2015

Independent

  • Biotech Consultant

    2010 - 2013

GI

Genomics Institute of the Novartis Research Foundation

  • Scientist

    2009 - 2009

    Novel targets and projects

Education

Investments

Bluejay Therapeutics

Series B

Total Funding: $220M

Biolinq

Series B

Total Funding: $110M

Scout Bio

Series B

Total Funding: $53M

SeQure Dx

Series A

Total Funding: $18M

Relevant Websites